Dreamit Health startup Biorealize, which created a desktop bioprototyping platform, is partnering with PUMA to showcase how the generation of athletic footwear, apparel and wearables can adapt in real-time by using living organisms to enhance performance.
Our mission at Dreamit Health is to empower startups to transform healthcare by providing access to customers, coaching, and capital. Founders enter the 14-week program to scale their businesses and to position themselves to raise their next round of funding. Meet the startups who were selected for the Spring 2018 Dreamit Health cohort.
Investor and developer Jeff Vinik announced a $12 million investment in Dreamit and will be joining the firm as a Partner and member of Dreamit’s Board of Directors. Dreamit works with top global health and urban technology startups (real estate tech, construction tech, smart buildings / smart city tech), providing access to extensive customer, industry, and investor networks during 14-week acceleration programs. Startups pitch, pilot, and partner with some of the largest organizations in real estate, construction, and healthcare.
Somatix employs real-time analysis of the three-dimensional vectors that represent hand motion, allowing it to identify and distinguish between our daily gestures, such as eating, drinking, smoking, taking medication or even shaving.
Dreamit Managing Director Andrew Ackerman discusses challenges with emerging market investing, what smart investors understand about timing, how accelerators compete, differentiate and win, and how angels and VCs need to think differently to drive returns.
Our friends at 43North are looking for awesome startups that are willing to relocate to Buffalo, NY and receive a $500k or $1M investment. 43North has crowned 37 winners since coming on the scene as part of Governor Andrew Cuomo’s Buffalo Billion initiative in 2014. Alumni of the program have gone on to raise more than $70 million. See their portfolio here.
Startups have a limited budget for marketing, so it's critical that they prioritize how those dollars are spent. Market segmentation can help startups prioritize their resources to achieve the largest impact with the leanest budget. It's a data-driven exercise and a key component of any marketing plan. In this webinar, Stephen Bouikidis and Mary Jordan of Magma Digital will present tools and tactics that enable founders to evaluate opportunities and reach new audiences.
Dreamit Health alum Somatix beat out over 40 other startups to win the first-ever "Market Disrupt" pitch competition at the "Employer Healthcare & Benefits Congress and World Medical Tourism & Global Healthcare Congress."
The International Health Innovation Summit is an event that will bring together health tech founders, investors, and other industry leaders to discuss exciting trends in global healthcare innovation. Dreamit will be speaking at the event and we hope to see you there!
Collision is one of America's fastest-growing tech conferences, and our team will be at the event meeting with startup founders and venture investors. Fill out this form to meet with us if you will be there!
Looking to learn from researchers and companies that are developing innovative technologies for the fight against cancer? Then you won't want to miss Philly Tech Week: Disrupting Cancer.
If you are a digital health or medical device startup heading to New Orleans for Collision, join us for a happy hour event immediately following the conference on Tuesday. This will be a great opportunity to meet other founders in the space, network with venture investors, and share strategies for operating in the healthcare field.
Dreamit Health Managing Director Adam Dakin will be speaking at the HLTH Conference in Las Vegas on May 6. Over the course of the conference, Adam will also be meeting with promising health tech startups to discuss the Dreamit Health program, give advice for fundraising, provide feedback on product, and get to know what founders are working on.
Enjoy breakfast and coffee while listening to several notable venture investors from the NYC community discuss the key characteristics of the companies they back.